# Anika Therapeutics, Inc.: Form SC 13D/A, filed Sep 11, 2023

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: SC 13D/A
- Filed: 2023-09-11
- Accepted by EDGAR: Sep 11, 2023, 06:01 ET
- Period: not reported
- Accession: 0000902664-23-004717
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000090266423004717/p23-2372sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000090266423004717/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000090266423004717/p23-2372sc13da.htm

Filed Sep 11, 2023.
Source: SEC EDGAR, the filing index for accession 0000902664-23-004717. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.